$OLK News

Last published 2y ago

2y agoOLKNotice to attend the Extra General Meeting of Olink Holding AB (publ)GlobeNewswireThis is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail. UPPSALA, Sweden, July 11, 2024 (GLOBE NEWSWIRE) -- The
2y agoOLK TMOThermo Fisher Scientific Completes Acquisition of Olink, Announces Commencement of Subsequent Offering PeriodBusiness WireSubsequent Offering Period Scheduled to Expire at 5:00 p.m., New York Time, on July 16, 2024 Thermo Fisher Scientific Inc. (NYSE:TMO) ("Thermo Fisher"), the world leader in serving science, today announced that it has
2y agoOLK TMOOlink Announces Receipt of CMA Clearance for Proposed Acquisition by Thermo FisherGlobeNewswireUPPSALA, Sweden, July 08, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) ("Olink") (NASDAQ:OLK) today announced that the UK Competition and Markets Authority (the "CMA") has unconditionally approved the previously
2y agoOLKReport from the Extra General Meeting of Olink Holding AB (publ) on 5 July 2024GlobeNewswireUPPSALA, Sweden, July 05, 2024 (GLOBE NEWSWIRE) -- At the Extra General Meeting (the "EGM") of Olink Holding AB (publ), reg. no 559189-7755, (the "Company"), the EGM adopted, inter alia, the following resolutions. For
2y agoOLKOlink® Introduces Global Network of Certified Service Providers to Accelerate Protein Biomarker DiscoveryGlobeNewswireUPPSALA, Sweden, July 03, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (NASDAQ:OLK), a global leader in proteomics, introduces its inaugural network of Olink® Certified Service Providers. The group of Olink
2y agoOLKNotice to attend the Extra General Meeting of Olink Holding AB (publ)GlobeNewswireThis is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail. UPPSALA, Sweden, June 11, 2024 (GLOBE NEWSWIRE) -- The
2y agoOLKOlink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute ConfidenceGlobeNewswireUPPSALA, Sweden, June 06, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (NASDAQ:OLK) today announced the introduction of Olink Target 48 Immune Surveillance, a validated multiplexed protein assay panel that offers a
2y agoOLKResearchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before DiagnosisGlobeNewswireUPPSALA, Sweden, May 30, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (NASDAQ:OLK) today reported the publication of a landmark study using the Olink Explore platform to identify proteins in the blood that may
2y agoOLKOlink reports first quarter 2024 financial resultsGlobeNewswireUPPSALA, Sweden, May 13, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) ("Olink") (NASDAQ:OLK) today announced its unaudited financial results for the first quarter ended March 31, 2024. Highlights First quarter
2y agoOLKReport from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024GlobeNewswireUPPSALA, Sweden, April 19, 2024 (GLOBE NEWSWIRE) -- At the Annual General Meeting (the "AGM") of Olink Holding AB (publ), reg. no 559189-7755, (the "Company"), on 19 April 2024 the AGM adopted, inter alia, the
2y agoOLKOlink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of DiseaseGlobeNewswireUPPSALA, Sweden, April 02, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (NASDAQ:OLK) today announced the availability of an open access data library consisting of over 300,000 protein-disease risk associations,
2y agoOLKOlink publishes 2023 annual reportGlobeNewswireUPPSALA, Sweden, March 25, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) ("Olink") (NASDAQ:OLK) today announced that the Annual Report for 2023 is now available on the Company's website at
2y agoOLKOlink reports fourth quarter and full year 2023 financial resultsGlobeNewswireUPPSALA, Sweden, March 25, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) ("Olink") (NASDAQ:OLK) today announced its unaudited financial results for the fourth quarter ended December 31, 2023. Highlights Fourth
2y agoOLKNotice to attend the Annual General Meeting of Olink Holding AB (publ)GlobeNewswireUPPSALA, Sweden, March 15, 2024 (GLOBE NEWSWIRE) -- The shareholders of Olink Holding AB (publ) (the "Company" or "Olink"), reg. no. 559189-7755, are hereby given notice to attend the Annual General Meeting to be held
2y agoOLKOlink announces change of date for Annual General MeetingGlobeNewswireUPPSALA, Sweden, March 08, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) ("Olink") (NASDAQ:OLK), today announced that Olink's 2024 Annual General Meeting ("AGM") will be held in Uppsala, Sweden on April 19th, 2024.
2y agoOLK TMOThermo Fisher Scientific Reports Fourth Quarter and Full Year 2023 ResultsBusiness WireThermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter and Full Year 2023
2y agoLAB OLK SLGC TMOMadryn Asset Management Issues Letter to Shareholders Correcting False and Misleading Statements in SomaLogic's Recent Investor PresentationBusiness WireHighlights Public Opposition to Proposed Merger from Skye Fund III, a Long-Term SomaLogic Investor Deeply Troubled by Information in Complaint Filed by Company Founder and Chief Technology Officer That Strongly
2y agoLAB OLK SLGCMadryn Asset Management Issues Presentation Detailing Why SomaLogic Shareholders Should Vote "AGAINST" the Value-Destructive and Deeply Flawed Proposed Merger with Standard BioToolsBusiness WireEncourages SomaLogic Shareholders to Visit www.NoSomaLogicMerger.com to View Presentation and Learn How to Vote "AGAINST" the Proposed Merger Madryn Plans to Send a GREEN Proxy Card to SomaLogic Shareholders, and
2y agoEXAS ILMN LAB ME+4Madryn Asset Management, a Top Shareholder of SomaLogic, Issues Letter Regarding Opposition to the Company's Proposed Merger with Standard BioToolsBusiness WireFiles Preliminary Proxy Statement to Solicit Shareholders to Oppose the Merger Intends to Vote AGAINST the Conflict-Plagued and Excessively Dilutive Transaction, Which Stands to Unduly Benefit Certain Investors and
2y agoOLKOlink reports third quarter 2023 financial resultsGlobeNewswireUPPSALA, Sweden, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) ("Olink") (NASDAQ:OLK) today announced its unaudited financial results for the third quarter ended September 30, 2023. Highlights Third
3y agoOLKNovogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomicsGlobeNewswireUPPSALA, Sweden, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) ("Olink") (NASDAQ:OLK) today announced that Novogene Asia Pacific Middle East and Africa (AMEA) has adopted the Olink Explore HT platform to
3y agoOLK TMOThermo Fisher Scientific Commences Tender Offer for All Outstanding Common Shares and ADSs of OlinkBusiness WireShareholders to Receive $26.00 per Common Share and ADS in Cash Thermo Fisher Scientific Inc. (NYSE:TMO) ("Thermo Fisher"), the world leader in serving science, and Olink Holding AB (publ) ("Olink") (NASDAQ:OLK), a
3y agoOLK TMOThermo Fisher Scientific Reports Third Quarter 2023 ResultsBusiness WireThermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Highlights Third quarter
3y agoOLK TMOThermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation ProteomicsBusiness WireEnhances Thermo Fisher's Capabilities in the High-Growth Proteomics Market with the Addition of Highly Differentiated Solutions Complements Existing Life Sciences and Mass Spectrometry Offerings, Accelerating Protein
3y agoOLKLandmark studies utilizing Olink® Explore technology signal a new era for population-scale proteogenomicsGlobeNewswireUPPSALA, Sweden, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (NASDAQ:OLK) today reported the publication of three articles in the prestigious scientific journal, Nature, that demonstrate the power of the
3y agoOLKAnnouncing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research.GlobeNewswireUppsala, Sweden, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research. Discover more with
3y agoOLKEurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision medicine programsGlobeNewswireUppsala, Sweden, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Eurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision medicine programs UPPSALA, Sweden, 12th September, 2023
3y agoOLKOlink to participate in September investor eventsGlobeNewswireUPPSALA, Sweden, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) ("Olink") (NASDAQ:OLK), today announced that Company management will participate in the following investor events: Goldman Sachs 20th Annual
3y agoOLKOlink Holding AB (publ) (OLK) Q2 2023 Earnings Call TranscriptEarnings Call Transcripts
3y agoOLKBaylor College of Medicine Human Genome Sequencing Center adopts Olink® Explore HT proteomics platformGlobeNewswireUPPSALA, Sweden, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) ("Olink") (NASDAQ:OLK) today announced that the Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC) has selected the Olink
3y agoOLKOlink to report second quarter 2023 financial results on August 9, 2023, and to participate in the Canaccord Genuity 43rd Annual Growth ConferenceGlobeNewswireUPPSALA, Sweden, July 13, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) ("Olink") (NASDAQ:OLK) today announced it will release financial results for the second quarter of 2023 before the market open on Wednesday,
3y agoOLKAnnouncing Olink® Explore HT – A New Era in ProteomicsGlobeNewswireUPPSALA, Sweden, July 12, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (NASDAQ:OLK) today announced the introduction of Olink® Explore HT, a transformational solution for high-throughput proteomics delivering
3y agoOLKRevealing the secrets of the human proteome with Olink® Insight: Exploring findings from one of the world's largest health studiesGlobeNewswireUPPSALA, Sweden, June 28, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (NASDAQ:OLK) today announced the availability of new findings into the variability of the human proteome, based on measurements of
3y agoDNLI DVA EVLO FHTX+5Cellarity Appoints Dr. Gregory J. Moore to Board of DirectorsBusiness WireCellarity, a life sciences company founded by Flagship
3y agoOLKOlink to participate in June investor eventsGlobeNewswireUPPSALA, Sweden, May 25, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) ("Olink") (NASDAQ:OLK), today announced that Company management will participate in the following investor events: William Blair 43rd Annual
3y agoOLKOlink reports first quarter 2023 financial resultsGlobeNewswireUPPSALA, Sweden, May 11, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) ("Olink") (NASDAQ:OLK) today announced its unaudited financial results for the first quarter ended March 31, 2023. Highlights First quarter
3y agoOLKReport from the Annual General Meeting of Olink Holding AB (publ) on 17 April 2023GlobeNewswireUPPSALA, Sweden, April 17, 2023 (GLOBE NEWSWIRE) -- At the Annual General Meeting (the "AGM") of Olink Holding AB (publ), reg. no 559189-7755, (the "Company"), on 17 April 2023 the AGM adopted, inter alia, the
3y agoOLKOlink to report first quarter 2023 financial results on May 11, 2023GlobeNewswireUPPSALA, Sweden, April 13, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) ("Olink") (NASDAQ:OLK) today announced it will release financial results for the first quarter of 2023 before the market open on Thursday, May
3y agoOLKSwedish Olink technology enables further development of South African research and innovationGlobeNewswireUPPSALA, Sweden, March 29, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (NASDAQ:OLK) today announced that the regional proteomic facility, D-CYPHR in Cape Town, South Africa has adopted Olink technology and has
3y agoOLKOlink publishes 2022 annual reportGlobeNewswireUPPSALA, Sweden, March 27, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) ("Olink") (NASDAQ:OLK) today announced that the Annual Report for 2022 is now available on the Company's website at
3y agoOLKBruno Rossi joins Olink as Chief Commercial OfficerGlobeNewswireUPPSALA, Sweden, March 21, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) ("Olink") (NASDAQ:OLK) today announced the appointment of life sciences industry veteran Bruno Rossi to the role of Chief Commercial Officer
3y agoOLKNotice to attend the Annual General Meeting of Olink Holding AB (publ)GlobeNewswireUPPSALA, Sweden, March 15, 2023 (GLOBE NEWSWIRE) -- The shareholders of Olink Holding AB (publ) (the "Company" or "Olink"), reg. no. 559189-7755, are hereby given notice to attend the Annual General Meeting to be held
3y agoOLKNUS Medicine implements Olink technology to accelerate precision medicine through next-generation proteomicsGlobeNewswireUPPSALA, Sweden, March 06, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (NASDAQ:OLK) today announced that the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) has launched the NUS
3y agoOLKOlink establishes agreement with Regeneron Genetics Center to scale their proteomics efforts, potentially enabling a new era of drug discoveryGlobeNewswireUPPSALA, Sweden, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (NASDAQ:OLK) today announced an agreement with Regeneron Genetics Center® (RGC) focused on the use and development of Olink High-Plex
3y agoOLKOlink reports fourth quarter and full year 2022 financial resultsGlobeNewswireUPPSALA, Sweden, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) ("Olink") (NASDAQ:OLK) today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2022.
3y agoOLKOlink Holding AB (publ) announces pricing of public offering of American Depositary SharesGlobeNewswireUppsala, Sweden, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (NASDAQ:OLK) ("Olink" or the "Company"), today announced the pricing of a public offering of 5,831,028 American Depositary Shares, each
3y agoOLKOlink Holding AB (publ) launches public offering of American Depositary SharesGlobeNewswireUppsala, Sweden, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (NASDAQ:OLK) ("Olink" or the "Company"), today announced the launch of a public offering of 5,831,028 American Depositary Shares, each
3y agoOLKOlink announces preliminary unaudited revenue for the fourth quarter and full year 2022 and provides outlook for 2023GlobeNewswireUPPSALA, Sweden, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) ("Olink" or the "Company") (NASDAQ:OLK), today announced preliminary unaudited revenue for the fourth quarter and year ended December 31, 2022,
3y agoOLKOlink to participate in the 41st Annual JP Morgan Healthcare ConferenceGlobeNewswireUPPSALA, Sweden, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) ("Olink") (NASDAQ:OLK), today announced its participation in the 41st Annual JP Morgan Healthcare Conference. Company management will present
3y agoOLK SEERDISCOVERY LIFE SCIENCES LAUNCHES WORLD-CLASS PROTEOMIC SERVICES DIVISION SUPPORTED BY LEADING TECHNOLOGY PARTNERSPR NewswireCreates a single source for large-scale population studies, biobank characterization, and multi-omic biomarker analysis to support drug and diagnostic development HUNTSVILLE, Ala., Dec. 14, 2022 /PRNewswire/ -- Discovery